» Articles » PMID: 23080367

African-Caribbean Ethnicity is Associated with a Hypercoagulable State As Measured by Thrombin Generation

Overview
Date 2012 Oct 20
PMID 23080367
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

African-Caribbean ethnicity is associated with an increased risk of both first and recurrent venous thromboembolism (VTE). The aim of this study was to evaluate thrombin generation in African-Caribbeans compared with whites in patients with deep vein thrombosis (DVT) and healthy volunteers. Thrombin generation was measured in a case-control study of 80 patients who had completed anticoagulation therapy for a first DVT (50 white and 30 African-Caribbean) and 66 controls. Peak thrombin with and without thrombomodulin was significantly higher in African-Caribbeans with DVT compared with whites with DVT (P < 0.001 for both comparisons) and African-Caribbean controls (P < 0.001, 0.003, respectively). Endogenous thrombin potential (ETP) with and without thrombomodulin was significantly higher in African-Caribbeans with DVT than whites with DVT (P ≤ 0.001 for both comparisons). Maximum velocity and ETP ratio were increased in African-Caribbeans with DVT compared with whites with DVT (P < 0.001 and 0.030, respectively) and African-Caribbean controls (P < 0.001 and 0.019, respectively). Within the control group, peak thrombin was significantly increased in African-Caribbeans compared with whites (P = 0.017). ETP, peak thrombin with thrombomodulin and maximum velocity were also increased in African-Caribbeans compared with white controls (P = 0.045 for all comparisons). African-Caribbeans with DVT had significantly higher factor VIII levels compared with whites with DVT and controls. African-Caribbean ethnicity confers a hypercoagulable state as measured by thrombin generation. This supports epidemiological findings of increased risk of first and recurrent VTE. Thrombin generation requires adjustment for ethnicity in studies undertaken in ethnically diverse populations.

Citing Articles

Factor VIII as a Novel Biomarker for Diagnosis, Prognosis, and Therapy Prediction in Human Cancer and Other Disorders.

Khalilian S, Mohajer Z, Ghafouri-Fard S Avicenna J Med Biotechnol. 2024; 16(2):68-80.

PMID: 38618505 PMC: 11007370. DOI: 10.18502/ajmb.v16i2.14857.


Classification of preeclampsia according to molecular clusters with the goal of achieving personalized prevention.

Than N, Romero R, Posta M, Gyorffy D, Szalai G, Rossi S J Reprod Immunol. 2023; 161:104172.

PMID: 38141514 PMC: 11027116. DOI: 10.1016/j.jri.2023.104172.


Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factors.

Temba G, Vadaq N, Wan J, Kullaya V, Huskens D, Pecht T J Thromb Haemost. 2022; 20(5):1089-1105.

PMID: 35102686 PMC: 9305795. DOI: 10.1111/jth.15657.


ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.

Ninivaggi M, de Laat-Kremers R, Carlo A, de Laat B Res Pract Thromb Haemost. 2021; 5(1):187-196.

PMID: 33537543 PMC: 7845068. DOI: 10.1002/rth2.12455.


Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19.

Frydman G, Boyer E, Nazarian R, Van Cott E, Piazza G Clin Appl Thromb Hemost. 2020; 26:1076029620943671.

PMID: 32702995 PMC: 7383642. DOI: 10.1177/1076029620943671.